Hemogenyx Pharmaceuticals plc , the biopharmaceutical group developing new therapies and treatments for blood diseases, announced the commencement of a strategic manufacturing partnership with WuXi ATU, a global contract testing development and manufacturing organisation (CTDMO).
HEMO-CAR-T cells are made using the company
